Live Breaking News & Updates on Gland pharma shares

Stay informed with the latest breaking news from Gland pharma shares on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Gland pharma shares and stay connected to the pulse of your community

gland pharma shares: Two entities sell 4.9 pc stake in Gland Pharma for Rs 1,411 cr

Two entities -- Lakumi Trust and Nicomac Machinery -- on Tuesday divested a 4.9 per cent stake in Gland Pharma for Rs 1,411 crore through open market transactions. Lakumi Trust and Nicomac Machinery Pvt Ltd disposed of 81.20 lakh shares of Gland Pharma in separate bulk deals on the National Stock Exchange (NSE).

China , Fosun-pharma , National-stock-exchange , Nicomac-machinery-pvt-ltd , Gland-pharma , Lakumi-trust , Nicomac-machinery , Gland-pharma-shares , Trust , Shares , Bulk-deal , Open

Two entities likely to sell 4.4% stake in Gland Pharma via block deals: Report

Nicomac Machinery and RP Advisory Services are looking at raising Rs 1,400 crore through the sale, and have set the floor price for the same at Rs 1,725/share. The floor price is at a discount of over 7% to the current market price of the stock. On Monday, shares of Gland Pharma ended nearly 6% higher on the NSE at Rs 1,856.

China , Mumbai , Maharashtra , India , Fosun-pharma , Ravi-penmetsa , Rp-advisory-services , National-stock-exchange , Citibank , Nicomac-machinery , Gland-pharma , Gland-pharma-news

gland pharma shares: Gland Pharma shares climb over 6% post Q2 results. Should you buy or sell?

Meanwhile, the company's earnings before interest, taxes, depreciation and amortization (EBITDA) came in at Rs 320.5 crore, up from Rs 297 crore in the year-ago period.

India , Motilal-oswal , Center-line , Gland-pharma , Axis-securities , Gland-pharma-shares , Gland-pharma-share-price , Gland-pharma-stock , Stock-market-news ,

Breakout Stocks: Breakout Stocks: How Gland Pharma, Caplin Point and HUDCO are looking on charts for Wednesday's trade

Stocks that were in action included names like Gland Pharma, which was up 20%, Caplin Point Laboratories, which gained 11%, and HUDCO, which was up more than 6% to hit a fresh 52-week high on Tuesday.

Sanket-thakar , Sanket-black , Gland-pharma , Caplin-point-laboratories , Alpha-bot , Simple-moving-average , Breakout-stocks , Caplin-point , Hudco , Gland-pharma-shares , Caplin-point-shares

Gainers & Losers: PB Fintech, Angel One among 5 stocks in spotlight on Tuesday

The S&P BSE Sensex ended at 65,846, down 107 points or 0.16% while the broader Nifty50 settled at 19,571, down 26 points or 0.13%. The banking gauge Nifty Bank finished 127 points or 0.28% higher at 44,964

Nifty-bank , Pb-fintech , Hindalco , Hero-motocorp , Gland-pharma-shares , Gland-pharma , Angel-one ,

Gland Pharma shares plunge 20%, hits 52-week low on weak Q4 results

Gland Pharma's stock plunged to a 52-week low of Rs 1070.8, after falling 20 per cent on BSE. The shares of Gland Pharma were locked in the lower limit.

Srinivas-sadu , Pashamylaram-telangana-penems , Gland-pharma-ltd , China-shanghai-fosun-pharmaceutical-group-co , Gland-pharma , Hyderabad-based-gland-pharma-ltd , Gland-pharma-shares , Land-pharma-news , Land-pharma-q4-results , Land-pharma-stock-price-today , Land-pharma-share-price ,

Gland Pharma: Near-term headaches, long-term gains

Analysts attribute the underwhelming gross margins to adverse product mix and an increase in cost pressures for the drugmaker

Gland-pharma , Q2-growth , Gross-margins , Input-cost-pressures , Gland-pharma-shares ,

Gland Pharma to announce four complex injectables during FY22; Q2 profit rises 38%

Announcing the Q2 FY22 financial results, CEO Srinivas Sadu stated that Gland Pharma is on track to make four complex injectable filing during the current financial year

Srinivas-sadu , Gland-pharma , Gland-pharma-complex-injectables , Gland-pharma-q2-results , Gland-pharma-profit , Gland-pharma-result , Gland-pharma-shares ,